Repurposed Generics For Rare Diseases: Janet Woodcock Proposes Shortcut

 
• By Grace Moser
  
A new approval pathway could allow non-commercial entities to find new uses for off-patent drugs. (Shutterstock)

More from Post-Marketing Regulation & Studies

More from United States